Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

por Ezhov, Marat V., Tmoyan, Narek A., Afanasieva, Olga I., Afanasieva, Marina I., Pokrovsky, Sergei N.
Publicado 2021

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level

por Afanasieva, Olga, Ezhov, Marat V., Klesareva, Elena, Razova, Oksana, Chubykina, Uliana, Egiazaryan, Mane, Sherstyuk, Ekaterina, Afanasieva, Marina, Utkina, Elena, Pokrovsky, Sergei
Publicado 2020

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction

por Afanasieva, Olga I., Ezhov, Marat V., Tmoyan, Narek A., Razova, Oksana A., Afanasieva, Marina I., Matchin, Yuri G., Pokrovsky, Sergei N.
Publicado 2022

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice

por Bachurin, Sergey O., Shelkovnikova, Tatyana A., Ustyugov, Alexey A., Peters, Owen, Khritankova, Ina, Afanasieva, Marina A., Tarasova, Tatyana V., Alentov, Igor I., Buchman, Vladimir L., Ninkina, Natalia N.
Publicado 2011

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types

por Ilina, Larisa N., Afanasieva, Olga I., Shiryaev, Andrey A., Vlasova, Elina E., Kurbanov, Said K., Afanasieva, Marina I., Ezhov, Marat V., Vasiliev, Vladislav P., Galyautdinov, Damir M., Pokrovsky, Sergey N., Akchurin, Renat S.
Publicado 2022